Intravitreal injection of triamcinolone acetonide for immune recovery uveitis.
Sirimaharaj
Maytinee
M
Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Australia.
Robinson
Michael R
MR
Zhu
Meidong
M
Csaky
Karl G
KG
Donovan
Basil
B
Sutter
Florian
F
Gillies
Mark C
MC
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy / Q000276:immunology; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007964:Leukocytosis / Q000188:drug therapy* / Q000276:immunology; D008269:Macular Edema / Q000188:drug therapy / Q000209:etiology; D008297:Male; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014605:Uveitis / Q000188:drug therapy* / Q000276:immunology; D014786:Vision Disorders / Q000188:drug therapy / Q000276:immunology; D014792:Visual Acuity; D014822:Vitreous Body
D000998:Antiviral Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide